The United States Food and Drug Administration (FDA) has approved Gablofen (baclofen injection) for use in the management of severe spasticity, a movement disorder often brought on by multiple sclerosis, cerebral palsy, spinal cord injury, brain trauma and stroke.
Gablofen is a drug whose generic name is Baclofen. Gablofen is an FDA approved medication that is used to manage severe spasticity. Severe spasticity is a medical condition caused by other conditions like multiple sclerosis and cerebral palsy. Gablofen belongs to a drug class that is known as Gamma-aminobutyric acid (GABA) agonists.